| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −9.3× | −1.7× | |
| Price / Book | 3.5× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −10.2× | −1.5× | |
| EV / EBITDA | −8.8× | −1.2× | |
| Earnings yield | −10.7% | −14.4% | |
| Free cash flow yield | −9.8% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,293.87 | +4.32% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.14 | +2.11% | $624.5B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.43 | +2.39% | $511.46B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.67 | +3.63% | $378.49B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.95 | +3.01% | $365.02B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.33 | +2.08% | $282.66B | 19.7× | 30.5% |
| +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.58 | +2.82% | $261.45B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $686.79 | +1.09% | $253.94B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.84 | +2.33% | $235.09B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.08 | +1.31% | $192.29B | 22.3× | 37.5% | +29.9% |
